EMLA cream as a topical anesthetic for the repeated mechanical debridement of venous leg ulcers: a double-blind, placebo-controlled study

J Am Acad Dermatol. 1999 Feb;40(2 Pt 1):208-13. doi: 10.1016/s0190-9622(99)70190-8.

Abstract

Background: A granulating surface is important for skin grafting and healing of leg ulcers. Mechanical debridement to remove necrotic tissue often must be stopped before completion because of pain.

Objective: Our purpose was to assess the effect of EMLA cream on the number of debridements required to obtain a clean ulcer and on pain during debridement and to determine its safety after repeated doses.

Methods: In this randomized double-blind, placebo-controlled study, 69 patients with venous leg ulcers received cream before debridement until a clean ulcer was obtained (or a maximum of 15 debridements).

Results: EMLA decreased the median number of debridements required for a clean ulcer (EMLA 11.5, placebo >15; P = .019) and decreased pain by 50% (P = .003). Plasma levels of lidocaine, prilocaine, and their main metabolites were low without any apparent accumulation.

Conclusion: EMLA produces effective pain relief for the debridement of leg ulcers and shortens the time to a clean ulcer.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Cutaneous
  • Aged
  • Anesthetics, Local* / administration & dosage
  • Anesthetics, Local* / blood
  • Debridement* / methods
  • Double-Blind Method
  • Female
  • Humans
  • Lidocaine* / administration & dosage
  • Lidocaine* / blood
  • Lidocaine, Prilocaine Drug Combination
  • Male
  • Ointments
  • Pain / prevention & control
  • Prilocaine* / administration & dosage
  • Prilocaine* / blood
  • Time Factors
  • Treatment Outcome
  • Varicose Ulcer / surgery*
  • Wound Healing

Substances

  • Anesthetics, Local
  • Lidocaine, Prilocaine Drug Combination
  • Ointments
  • Prilocaine
  • Lidocaine